Evidence map›Paper›PMID 39382326›Full record

ArticleACS chemical neuroscience2024

Comment on "Extracellular Vesicles Slow Down Aβ(1-42) Aggregation by Interfering with the Amyloid Fibril Elongation Step".

Mohsin Shafiq, Andreu Matamoros-Angles, Sussane Caroline Meister, Markus Glatzel

Abstract readComment
In one paragraph

Article in ACS chemical neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Mohsin ShafiqInstitute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.ORCID 0000-0002-4974-8955
Andreu Matamoros-AnglesInstitute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
Sussane Caroline MeisterInstitute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
Markus GlatzelInstitute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Halipi et al. explored the impact of extracellular vesicles (EVs) on amyloid-β (Aβ) aggregation. They concluded that EVs reduce Aβ aggregation, as seen by shorter and thicker fibrils. While we agree with the complex role of EVs in Alzheimer's disease, we are sceptical of the claim that EVs slow down Aβ aggregation, noting missing key references. Previous literature rather suggests that EVs (derived from neuronal cell lines) accelerate the process of Aβ fibrillation and plaque formation. Halipi et al.'s findings may be skewed due to the lack of essential neuronally expressed Aβ-binding partners, like the prion protein (PrP

Indexed as

Amyloid beta-PeptidesExtracellular VesiclesPeptide FragmentsAlzheimer DiseaseAmyloidAnimalsHumansProtein Aggregation, PathologicalAmyloidAmyloid beta-Peptidesamyloid beta-protein (1-42)Peptide FragmentsaggregationAlzheimer’s diseaseamyloid-β (Aβ)cellular prion protein (PrPC)Extracellular vesicles (EVs)thioflavin-T (ThT) assay

Identifiers

PMID39382326
PMCPMC11587504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.